<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="../../external.html?link=http://www.w3.org/1999/xhtml"><head><title>Issues Berkeley Medical Journal</title>



  

  
  
  <meta http-equiv="content-language" content="English" />

  
  <meta name="description" content="ISSUES Berkeley Medical Journal--Berkeley undergraduate science, medicine, and health journalism." />

  
  <meta name="keywords" content="Issues, berkeley, university, california, journalism, science, medicine, undergraduate, journal, ISSUES Berkeley Medical Journal, Issues Berkeley" />

  
  <meta name="owner" content="ISSUES Berkeley Medical Journal" />

  
  <meta name="revisit-after" content="20 days" />

  
  <meta name="rating" content="General" />

  
  <meta name="robots" content="all" />

  
  <link rel="stylesheet" type="text/css" href="../style.css" /></head><body>
<div id="container">
<!--

******************************

	Header + Navigation

******************************

-->
<div id="header"><a href="../index.html"><img src="../images/logo.jpg" style="border: 0px solid ; float: left; width: 246px; height: 40px;" alt="" align="left" /></a></div>
<div id="nav">
<ul>
  <li><a href="contactus.html" title="Contact Us">Contact&nbsp;Us</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="aboutus.html" title="About Us">About&nbsp;Us</a></li>
  <li><a href="index.html" title="Home">Home</a></li>
</ul>
</div>
<!--

******************************

	News Updates Column

******************************

-->
<div id="newsupdate">
<h1>Links and Updates</h1>
<div class="newstitle">.site<span>Navigation*</span></div>
<div id="MainText-left">
<ul>
  <li><a href="index.html" title="Home">Home</a></li>
  <li><a href="aboutus.html" title="About Us">About Us</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="staff.html" title="Staff">Staff</a></li>
  <li><a href="joinus.html" title="Opportunities">Join Us<br />
    </a></li>
  <li><a href="advertise.html" title="Advertisements">Advertise</a></li>
  <li><a href="contactus.html" title="Contact Us">Contact Us</a></li>
</ul>
</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div class="newstitle"><span><br />
</span></div>
<br />
<p><b><br />
<br />
</b></p>
<div class="newstitle"><span><b><br />
</b></span></div>
<b><br />
</b>
<p><b><b><br />
<br />
<br />
<a href="../../external.html?link=http://www.ocf.berkeley.edu/">
<br />
</a> </b></b></p>
</div>
<!--

******************************

   Welcome Message IMG+TEXT

******************************

-->
<div class="rightcontainer">
<div id="welcome"><b><b>science. medicine. health.</b></b></div>
<div id="content">
<p style="text-align: center;"><a href="15.1_Lai_R_Cheap_And_Easy_1.html"><small><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;">return to
previous page</span></small></a></p>
<p style="text-align: center;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;"><a href="15.1_Issue.html"><small>return
to issue</small></a><br />
</span></p>
<p><br />
</p>
<p style="font-style: italic;"><small>continued from Cheap and Easy</small></p>
<p><small><br />
</small></p>
<p><small> &nbsp;&nbsp; Skeptics argue that DCA research is years away
from clinical trials because of a lack of funding. The chemical
structure of DCA is too simple and inexpensive to produce so it is
unattractive to pharmaceutical companies that only fund research that
will produce patents or profits. Drug patents last for 20 years and
grant pharmaceutical companies the exclusive rights to produce, market,
and profit from a particular drug in that time span. Unfortunately, DCA
has already been on the market for decades now as a treatment for
lactic acidosis. Critics point out that the process of getting funding
for this unpatented and unprofitable drug will be extensive.<br />
<br />
&nbsp;&nbsp;&nbsp; According to a February 1993 report by the
Congressional Office of Technology Assessment, it costs a company $359
million on average to get one new medicine from the laboratory to the
pharmacist&#8217;s shelf. Pharmaceutical companies know other chemotherapy
drugs are more profitable, thus researchers, including Michelakis&#8217;s
group, will face a difficult road ahead in gaining additional financial
support. In a recent online letter to the public, Michelakis says that
his team will need to raise $1.5 million for the initial research in
humans to begin. Currently, Michelakis&#8217;s research is funded by the
Canadian Institutes for Health Research, Alberta Heritage Foundation
for Medical Research, and Canadian Foundation for Innovation, as well
as by private donations. &#8220;The dogma right now about developing drugs is
that they can&#8217;t be developed from research without funding from
industry. Their sole purpose is profit,&#8221; remarks Michelakis.<br />
<br />
&nbsp;&nbsp;&nbsp; In the end, cancer patients are caught in the battle
between pharmaceutical companies and drug researchers. The patients
suffer most, since they are the ones waiting hopefully for potential
&#8220;miracle cures&#8221; like DCA to be approved by the Food and Drug
Administration. Michelakis and his team will need to conduct more
research and gain more funding before DCA can be used as a cancer
treatment. &#8220;Patients have to approach this with guarded optimism. Lots
of examples appear promising in animals but not in the case of humans,&#8221;
says Michelakis. Ultimately, drug research should be intended to
improve patient welfare because the advantages of an inexpensive
treatment for cancer treatment drug are invaluable.<br />
ext of Article.</small><br />
<br />
</p>
<p>
</p>
<h3><b><b><b><b>About the Author
</b></b></b></b></h3>
<p>
</p>
<p><small>Raymond Lai is a fourth year Molecular and Cell Biology major
who believes laughter is the greatest cure because you cannot spell
&#8220;medication&#8221; without having a &#8220;comedian&#8221; in &#8220;it.&#8221;</small></p>
<p><br />
</p>
<p style="text-align: center;"><a href="15.1_Lai_R_Cheap_And_Easy_1.html"><small>return to previous
page</small></a></p>
<p style="text-align: center;"><a href="15.1_Issue.html"><small>return
to issue</small></a><br />
</p>
<p style="text-align: center;"><br />
</p>
<div style="text-align: right;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;" /></div>
</div>
</div>
<div id="footer"> Copyright © 2007 ISSUES Berkeley Medical Journal |
Designed by MockUp | <a href="mailto:bmjwebm@gmail.com">Contact
Webmaster </a><br />
Not an official University publication. Content not necessarily
reflective of UC Berkeley or the ASUC.</div>
</div>

</body></html>